Wellgen Medical expands to the United States – On-site demo at Johns Hopkins Medicine

Wellgen Medical is now in the USA! The company conducted a live demonstration at the David H. Koch Cancer Research Building, Johns Hopkins Medicine in Baltimore, MD, showcasing its proprietary Tomographic Scanning (Cytology Tomography Scan) technology to a distinguished audience of medical experts.

This milestone marks Wellgen's official entry into the U.S. market, bringing its advanced imaging technology to one of the world's leading centers for cancer research and clinical care.

Through this collaboration with world-class experts in cytopathology at Johns Hopkins Medicine, Wellgen is exploring new frontiers in cancer diagnosis and treatment. This expansion reflects the company's growing global reach and its continued commitment to advancing "AI-Assisted Diagnosis" on an international scale.